Cellosaurus HMC-1.3 clone 1H9 (CVCL_E8DV)
| Cell line name | HMC-1.3 clone 1H9 |
|---|---|
| Accession | CVCL_E8DV |
| Resource Identification Initiative | To cite this cell line use: HMC-1.3 clone 1H9 (RRID:CVCL_E8DV) |
| Comments | Characteristics: Compared to the parent cell line has reduced activity in pathways involved in survival, cell-to-cell adhesion, and neoplasia with differences in expression of molecular components and cell surface markers (PubMed=37025992). Characteristics: Produces significantly smaller tumors than the parent cell line when subcutaneously inoculated in mice (PubMed=37025992). Doubling time: 24 hours (ABM=T8388). Omics: Transcriptomics; RNAseq. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Cell type: Mast cell; CL=CL_0000097. |
| Sequence variations |
|
| Disease | Mast cell leukemia (NCIt: C3169) Mast cell leukemia (ORDO: Orphanet_98851) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_H205 (HMC-1.2) |
| Sex of cell | Male |
| Age at sampling | 52Y |
| Category | Cancer cell line |
| Publications | PubMed=37025992; DOI=10.3389/fimmu.2023.1078958; PMCID=PMC10071028 |
| Cross-references | |
| Cell line collections (Providers) | ABM; T8388 |
| Gene expression databases | GEO; GSM6674143
GEO; GSM6674144 GEO; GSM6674145 |
| Entry history | |
| Entry creation | 10-Apr-2025 |
| Last entry update | 10-Apr-2025 |
| Version number | 1 |